Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02345109Not ApplicableCompleted

Clinical Trial of Transtek Body Fat Analyzer (GBF-835-N2 & Other 7 Models)

Role: lead

NCT01763775Not ApplicableCompleted

Clinical Trial of Transtek Body Fat Analyzer (GBF-1251-B & Other 3 Models)

Role: lead

NCT01662947Not ApplicableCompleted

Clinical Study of Wrist Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard

Role: lead

NCT01502553Not ApplicableCompleted

Clinical Study of Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10

Role: lead

NCT01296048Completed

Clinical Test for Transtek Glass Body Analyzer

Role: lead

NCT01440894Completed

Clinical Trail of Transtek Glass Body Fat Analyzer

Role: lead

All 6 trials loaded